Cargando…
Increased Growth Differentiation Factor 15 in Patients with Hypoleptinemia-Associated Lipodystrophy
Objective. Similar to obesity, lipodystrophy (LD) causes adipose tissue dysfunction and severe metabolic complications. Growth differentiation factor 15 (GDF15) belongs to the transforming growth factor β superfamily and is dysregulated in metabolic disease including obesity and diabetes mellitus. C...
Autores principales: | Kralisch, Susan, Hoffmann, Annett, Estrada-Kunz, Juliane, Stumvoll, Michael, Fasshauer, Mathias, Tönjes, Anke, Miehle, Konstanze |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582938/ https://www.ncbi.nlm.nih.gov/pubmed/33003626 http://dx.doi.org/10.3390/ijms21197214 |
Ejemplares similares
-
Metreleptin Robustly Increases Resting-state Brain Connectivity in Treatment-naïve Female Patients With Lipodystrophy
por: Schlögl, Haiko, et al.
Publicado: (2023) -
Leptin Improves Parameters of Brown Adipose Tissue Thermogenesis in Lipodystrophic Mice
por: Hoffmann, Annett, et al.
Publicado: (2021) -
Reward Processing During Monetary Incentive Delay Task After Leptin Substitution in Lipodystrophy—an fMRI Case Series
por: Schlögl, Haiko, et al.
Publicado: (2023) -
Marked Hypoleptinemia Precedes Overt Fat Loss in Immune Checkpoint Inhibitor-induced Acquired Generalized Lipodystrophy
por: Dhanasekaran, Maheswaran, et al.
Publicado: (2023) -
Suggestive Evidence for an Antidepressant Effect of Metreleptin Treatment in Patients with Lipodystrophy
por: Vieira, Diana Branco, et al.
Publicado: (2022)